Join to view full profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Valero is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Medical Branch HospitalsFellowship, Hematology and Medical Oncology, 1987 - 1988
University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 1985 - 1987
St Elizabeth Youngstown Hospital/NEOMEDResidency, Internal Medicine, 1982 - 1985
Universidad Autonoma de Nuevo LeonClass of 1980
Certifications & Licensure
FL State Medical License 2021 - Present
TN State Medical License 2023 - 2028
GA State Medical License 2023 - 2027
MS State Medical License 2023 - 2027
TX State Medical License 1987 - 2027
AZ State Medical License 2023 - 2026
LA State Medical License 2023 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013, 2015
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013, 2015
- Super Doctor SuperDoctors.com
Clinical Trials
- Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine Start of enrollment: 2007 May 23
- Exemestane-RAD001-Metformin Start of enrollment: 2012 Sep 01
- T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
Publications & Presentations
PubMed
- ASO Visual Abstract: Clinical Impact and Outcomes of Neoadjuvant Systemic Therapy for Invasive Lobular Carcinoma.Genevieve A Fasano, Jason Mouabbi, Helen M Johnson, Heather Y Lin, Kerollos Nashat Wanis
Annals of Surgical Oncology. 2026-07-06 - Clinical Impact and Outcomes of Neoadjuvant Systemic Therapy for Invasive Lobular Carcinoma.Genevieve A Fasano, Jason Mouabbi, Helen M Johnson, Heather Y Lin, Kerollos Nashat Wanis
Annals of Surgical Oncology. 2026-07-03 - Stage-related transcriptional changes in HR-positive/HER2-negative breast cancer.William S O Symmans, Kevin Tran, Chunxiao Fu, Hongxia Sun, Rebekah Gould
NPJ Breast Cancer. 2026-07-02
Press Mentions
Adding Carboplatin to Standard Adjuvant Chemotherapy Does Not Improve Survival in Triple-Negative Breast CancerJune 1st, 2025- MD Anderson Researchers Showcase Groundbreaking Multi-Cancer Studies at ASCOMay 23rd, 2025
- Inflammatory Breast Cancer Survivor Finds Hope at MD AndersonOctober 26th, 2023
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
